X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-09 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale | $16.33 | -2,812 | 205,605 | -1% | -$45,915 | ||||||
| D | 2023-05-15 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $29.03 | -11,965 | 208,417 | -5% | -$347,358 | |||||
| D | 2023-04-17 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $30.54 | -49,579 | 208,417 | -19% | -$1,513,942 | |||||
| AD | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $31.87 | -54,627 | 208,417 | -21% | -$1,741,200 | |||||
| D | 2023-03-16 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale+OE | $31.87 | -54,627 | 158,839 | -26% | -$1,741,200 | |||||
2023-01-06 | AMLX | Yeramian Patrick D | Chief Medical Officer | S - Sale | $36.30 | -2,034 | 204,299 | -1% | -$73,831 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |